Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa.

Abstract

OBJECTIVE Although many HIV-infected (HIV+) and HIV-exposed but uninfected (HEU) infants have received live rotavirus vaccines since the WHO recommended universal administration of these vaccines to infants, there has been limited prospective information on their safety and immunogenicity in either group of infants. DESIGN/METHODS We performed a… (More)

Topics

Cite this paper

@article{Levin2017SafetyAI, title={Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa.}, author={Myron J. Levin and Jane C. Lindsey and Susan S Kaplan and Werner Schimana and Jody Lawrence and Monica M Mcneal and Mutsa F Bwakura-Dangarembizi and Anthony C Ogwu and Evans Mwila Mpabalwani and Paul Sato and George K. Siberry and Margaret Nelson and Darcy A. Hille and Geoffrey A. Weinberg and Adriana Weinberg}, journal={AIDS}, year={2017}, volume={31 1}, pages={49-59} }